Csrnewsdaily.com Issues Investment Alert On (OTC:MCLN), (OTC:BGNN), (OTC:SCRA), (OTC:CTIX), (AMEX:VRNG)
POMPANO BEACH, FL, Dec 27, 2012 (eTeligis.com via COMTEX)
MedClean Technologies Inc (OTC:MCLN) declined 50% to $0.0001 at a traded volume of 1.50 million shares. The Company designs and manufactures onsite regulated medical waste processing systems. The Company offers MedClean System that enables hospitals and other healthcare providers to convert bio-hazardous regulated medical waste into sterile unrecognizable material suitable for disposal as municipal solid waste. The Price/Sale ratio of the Company is 0.59.
Will MCLN Move Higher After Today's Sudden Selling Activities Don't Miss The Free Trend Analysis here http://csrnewsdaily.com/c1/ company=MCLN
B Green Innovations, Inc(OTC:BGNN) is currently trading at $0.0004 at a traded volume of 1.25 million shares. The Company focuses on acquiring and identifying technologies that address environmental issues. The company also supports the interactive voice response software, which is designed to read information from and write information to databases, as well as to query databases and return information. The Price/Sale ratio of the Company is 0.94.
How Should Investors Trade BGNN After The Recent Momentum, Find Out Here http://csrnewsdaily.com/c1/ company=BGNN
SecureAlert Inc (OTC:SCRA) declined 1.93% to $0.0711 at a traded volume of 1.19 million shares. The Market Cap of the Company is 43.98 million. The 52 week range of the stock is 0.01 to 0.08. The Company has specialized in electronic monitoring of offenders including pretrial, probation and parole.
Get Free Special Trend Analysis On SCRA Here http://csrnewsdaily.com/c1/ company=SCRA
CellceutixCorp(OTC:CTIX) declined 8.68% to $2.21 at a traded volume of 1.52 million shares. The Company provides commentary on a front page New York Times article published December 23, 2012 titled, "Genetic Gamble; New Approaches to Fighting Cancer."The Company is a clinical stage biopharmaceutical company focused on discovering small molecule drugs to treat unmet medical conditions, including drug-resistant cancers and autoimmune diseases.
The Company said that its clinical trials of its flagship anti-cancer drug Kevetrin have advanced to the next cohort.
Get Free Special Trend Analysis On CTIX Here http://csrnewsdaily.com/c1/ company=CTIX
Vringo, Inc (NYSEAMEX:VRNG) declined 3.11% to $2.80 at a traded volume of 1.04 million shares. The Market Cap of the Company is 224.92 million. The Company develops and provides software products for mobile video entertainment, personalization, and mobile social applications. The Price/Sale ratio of the Company is 872.74 and Price/Book ratio is 2.08. The 50-Day Moving Average and 200-Day Moving Average of the Company is 3.34 and 3.58 respectively.
Get Free Special Trend Analysis On VRNG Here http://csrnewsdaily.com/c1/ company=VRNG
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Pacific Dynasty Consultants Inc.
2637 E Atlantic Blvd #22611 Pompano Beach, FL 33062323-287-5171
Associated Documentation:Link to submission on http://www.eteligis.comCSRNewsDaily.com_12-27-2012_SMU_2.docx
[ Back To Homepage ]